Cyclo Therapeutics to Participate in the Virtual Investor Niemann-Pick Disease Type C Spotlight Event

Author's Avatar
May 09, 2022

Cyclo+Therapeutics%2C+Inc. (Nasdaq: CYTH) (“Cyclo Therapeutics” or the “Company”), a late clinical stage biotechnology company dedicated to developing life-changing medicines through science and innovation for patients and families living with diseases, today announced it will participate in the Virtual+Investor+Niemann-Pick+Disease+Type+C+%28NPC%29+Spotlight event on Monday, May 16, 2022 at 2:00 PM ET.